20.08.2018 • News

Brenntag Buys Belgium’s Alphamin

Brenntag Buys Belgium’s Alphamin (c) Brenntag
Brenntag Buys Belgium’s Alphamin (c) Brenntag

Brenntag has bought specialty chemicals distributor Alphamin from Belgium’s KeBek Private Equity, marking the fourth acquisition for the German distribution giant this year. Financial terms were not disclosed.

The deal includes Alphamin headquartered in Wavre, Belgium, and its US subsidiary based in New Jersey. Alphamin supplies specialty polymers and waxes to customers in a wide range of industries, including construction, building materials, automotive, cosmetics, printing and plastics. The company also has an application center in Belgium, where it carries out R&D and quality control services.

Alphamin has 20 employees and generated sales of approximately €45 million in the financial year ending Jun. 30, 2018.

“With its global reach, its product portfolio and expertise, Alphamin is an attractive bolt-on acquisition for Brenntag’s existing specialty chemicals business, strengthening and expanding our existing offer to customers in the material science segment,” said Karsten Beckmann, member of the board of management of Brenntag Group and CEO of Brenntag Europe, Middle East and Africa (EMEA).

KeBeK Private Equity acquired a majority stake in Alphamin in January 2014 since when it said it has successfully optimized the Belgium company’s product portfolio.

Brenntag’s other acquisitions this year include Canada Colors and Chemicals in July, together with Portugal’s Quimitecnica and a 65% stake in India’s Raj Petro Specialties in May.

Company

Logo:

Brenntag SE

Messeallee 11
45131 Essen
Germany

Company contact







Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.